2FC-25625-28899 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-22
Dose 1 — Pfizer-BioNTech
2021-09-23
Registered in v-safe
2021-09-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-24
Survey response — days 1–6 daily, dose 1
MedDRA: Pain, Pain in extremity — Feeling: Good

Free text: Sore arm when I lift it

MedDRA releases: 2024-11 · check-in free text available
2021-09-29
Survey response — day 7, dose 1
MedDRA: Pre-existing disease, Psoriasis — Feeling: Fair

Free text: Psoriasis flair up

MedDRA releases: 2024-11 · check-in free text available
2021-12-22
Survey response — 3 months, dose 1
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: I have a cold

MedDRA releases: 2024-11 · check-in free text available
2022-09-22
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-22	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-24

Systemic reaction (other): Sore arm when I lift it

Release 9 — day 7, dose 1

2021-09-29

Systemic reaction (other): Psoriasis flair up

Release 10 — 3 months, dose 1

2021-12-22

Symptoms: I have a cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SRO	Pain	·	·	✓
SRO	Pain in extremity	·	·	✓
SRO	Pre-existing disease	·	·	✓
SRO	Psoriasis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release